Predict your next investment

Corporation
corixbioscience.com

See what CB Insights has to offer

About Corix Bioscience

Corix Bioscience is a developer of proprietary cannabis and industrial hemp strains using tissue cell cultures to propagate living plants to be used in the pharmaceutical medical industries.

Corix Bioscience Headquarter Location

34225 N 27th Drive Bldg 5, Suite 238

Phoenix, Arizona, 85085,

United States

623-551-5808

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Corix Bioscience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Corix Bioscience in 1 Expert Collection, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest Corix Bioscience News

SEC Suspends Trading in Cannabis Company Focused on Nevada and California

Apr 13, 2018

The SEC moved today to suspend trading in Corix Bioscience (OTC: CXBS), questioning the accuracy of information it has provided: The Commission temporarily suspended trading in the securities of Corix Bioscience, Inc. because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning, among other things, the company’s assets and operations in Nevada. This information includes claims that CXBS holds a valid, state-issued export license in Nevada for growing, processing, and distributing industrial hemp. The company’s website includes a copy of the license in question: The company, which was previously known as IX Biotechnology, merged into American Housing Income Trust in March, 2017, subsequently changing its name. Corix stated that it intended to be the largest producer of CBD in the United States. The company, which is focused on California, Oregon and Nevada, claims to have operations in Africa and the UK as well as a license to import into Switzerland. Corix hasn’t yet filed its 10-K for the year ending in December 2017, with its most recent 10-Q filed in November. Subsequent to that filing, it issued an 8-K that detailed claims that shareholder signatures had been forged : Corix Bioscience, Inc., a Wyoming corporation (the “Company”) files this Current Report on Form 8-K to disclose information revealed to the Company through the sworn testimony of three shareholders: George Elam, William Bills, and Joaquin Flores (the “Shareholders”). The Shareholders claim that certain documents bearing their signatures are not authentic, were not signed by them, and were not signed with their permission. Trading in the stock is suspended until April 27th. Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Corix Bioscience Acquisitions

1 Acquisition

Corix Bioscience acquired 1 company. Their latest acquisition was Pharmaceutical Development Corp on November 07, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/7/2017

$99M

Acquired

1

Date

11/7/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.